Adverum Biotechnologies Balance Sheet Health
Financial Health criteria checks 6/6
Adverum Biotechnologies has a total shareholder equity of $144.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $234.4M and $90.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$153.24m |
| Equity | US$144.12m |
| Total liabilities | US$90.26m |
| Total assets | US$234.38m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0HA3's short term assets ($161.1M) exceed its short term liabilities ($27.7M).
Long Term Liabilities: 0HA3's short term assets ($161.1M) exceed its long term liabilities ($62.6M).
Debt to Equity History and Analysis
Debt Level: 0HA3 is debt free.
Reducing Debt: 0HA3 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0HA3 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0HA3 has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 8.9% each year.